Begin typing your search above and press return to search.
proflie-avatar
Login
exit_to_app
Can Trump wield his big stick?
access_time 22 Nov 2024 10:39 AM GMT
election commmission
access_time 22 Nov 2024 4:02 AM GMT
Champions Trophy tournament
access_time 21 Nov 2024 5:00 AM GMT
The illness in health care
access_time 20 Nov 2024 5:00 AM GMT
The fire in Manipur should be put out
access_time 21 Nov 2024 9:19 AM GMT
America should also be isolated
access_time 18 Nov 2024 11:57 AM GMT
DEEP READ
Munambam Waqf issue decoded
access_time 16 Nov 2024 5:18 PM GMT
Ukraine
access_time 16 Aug 2023 5:46 AM GMT
Foreign espionage in the UK
access_time 22 Oct 2024 8:38 AM GMT
exit_to_app
Homechevron_rightIndiachevron_rightAstraZeneca serves...

AstraZeneca serves legal notice to SII over delay in vaccine supply

text_fields
bookmark_border
AstraZeneca Vaccine
cancel
camera_altRepresentational image only

British pharmaceutical company AstraZeneca on Wednesday served a legal notice to Adar Poonawalla's Serum Institue of India in Pune over delays in supplying the Covid vaccine.

Poonawalla mentioned that the production capacity of Covishield is under pressure given the increased domestic demand. As per reports, he added that the pause on Covishield's foreign shipments and the 'first claim' deal with India is difficult to explain abroad where these vaccines are sold at a higher price. This is despite AstraZeneca's announcement to supply the vaccine to 142 countries in March as part of its efforts to ensure equitable access to the vaccine.

Meanwhile, the first of millions of doses of Asterzeneca's COVAX, developed with its partner SII, have begun arriving in several low and middle-income countries, informed AstraZeneca. First COVAX shipments were dispatched to Ghana and Cote D'Ivoire, and countries including the Philippines, Indonesia, Fiji, Mongolia and Moldova. AstraZeneca expects further shipments in the coming weeks and hopes to provide 142 countries with hundreds of millions of doses in the coming months.

Show Full Article
TAGS:SIIAstraZeneca-Oxford Covid vaccine.
Next Story